Ibuprofen And Famotidine Tablet, Film Coated
NDC Package 70518-4580-0
Package Information
Ibuprofen And Famotidine tablets is ibuprofen and famotidine tablet, a combination of the NSAID ibuprofen and the histamine H 2-receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer, in patients who are taking ibuprofen for those indications. This formulation utilizes a tablet, film coated delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4580 and is authorized under FDA application ANDA211890.
Identification & Billing
- RxCUI: 1100066 - ibuprofen 800 MG / famotidine 26.6 MG Oral Tablet
- RxCUI: 1100066 - famotidine 26.6 MG / ibuprofen 800 MG Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Histamine H2 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-2 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 70518 - Remedyrepack Inc.
- 70518-4580 - Ibuprofen And Famotidine
- 70518-4580-0 - 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 70518-4580 - Ibuprofen And Famotidine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70518-4580-0 identifies a specific commercial package of 60 tablet, film coated in 1 bottle, plastic of Ibuprofen And Famotidine, a human prescription drug labeled by Remedyrepack Inc.. This tablet, film coated is formulated for oral use and contains famotidine; ibuprofen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on March 05, 2026. The current certification is valid through December 31, 2027.
How is this Remedyrepack Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518458000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.